Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insulin resistance and vessel endothelial function.

A J H H M van Oostrom1, M Castro Cabezas, T J Rabelink

  • 1Department of Vascular Medicine, University Hospital Utrecht, F02.126, PO Box 85500, 3508 GA Utrecht, The Netherlands.

Journal of the Royal Society of Medicine
|September 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The "SMART" side of hypertriglyceridemia.

Atherosclerosis·2025
Same author

Familial Combined Hyperlipidemia: Myth or Reality?

Current atherosclerosis reports·2025
Same author

Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritis.

Clinical rheumatology·2025
Same author

The addition of the sFlt-1/PlGF ratio to the protein/creatinine ratio in multiple pregnancy: Post-hoc analysis of the PREPARE cohort study.

Pregnancy hypertension·2024
Same author

Ultrastructural characterization of maturing iPSC-derived nephron structures upon transplantation.

Microscopy research and technique·2023
Same author

Clinical value and cost analysis of the sFlt-1/PlGF ratio in addition to the spot urine protein/creatinine ratio in women with suspected pre-eclampsia: PREPARE cohort study.

BMC pregnancy and childbirth·2022

Insulin Resistance Syndrome (IRS) involves metabolic disorders impacting endothelial function. Addressing dyslipidaemia, alongside lifestyle changes and glucose control, is crucial for improving vascular health and preventing complications.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Endocrinology

Background:

  • Insulin Resistance Syndrome (IRS) is characterized by metabolic disorders including hyperglycemia, hyperinsulinemia, and dyslipidemia.
  • Endothelial dysfunction is a key factor in atherosclerosis development within IRS.
  • Hyperglycemia and hyperlipidemia negatively impact endothelial function in both fasting and postprandial states, involving reactive oxygen species (ROS) and vasoactive molecules.

Purpose of the Study:

  • To review the role of endothelial dysfunction in IRS pathogenesis.
  • To evaluate current and potential therapeutic strategies for improving endothelial function in IRS patients.
  • To highlight the impact of different IRS components on vascular health.

Main Methods:

  • Literature review of studies on IRS, endothelial function, and atherosclerosis.

Related Experiment Videos

  • Analysis of the effects of hyperglycemia, hyperinsulinemia, and dyslipidemia on the endothelium.
  • Examination of therapeutic interventions targeting IRS and their impact on endothelial function.

    • Main Results:

    • Lifestyle modifications (smoking cessation, balanced diet with antioxidants, L-arginine, omega-3 fatty acids) are initial treatment priorities.
    • Strict glucose control improves endothelial function and reduces microvascular complications.
    • Improvements in macrovascular complications are primarily achieved by managing dyslipidemia, alongside other IRS characteristics.

    Conclusions:

    • Therapeutic strategies for IRS should prioritize lifestyle changes, strict glucose control, and particularly dyslipidemia management.
    • ACE inhibitors, thiazolidinediones, tetrahydrobiopterin, and folic acid supplementation show promise.
    • Further research into therapeutic neovascularization for endothelial dysfunction in IRS is warranted.